Dopamine transporter-dependent and -independent actions of trace amine beta-phenylethylamine - PubMed (original) (raw)
Dopamine transporter-dependent and -independent actions of trace amine beta-phenylethylamine
Tatyana D Sotnikova et al. J Neurochem. 2004 Oct.
Free article
Abstract
Beta-phenylethylamine (beta-PEA) is an endogenous amine that is found in trace amounts in the brain. It is believed that the locomotor-stimulating action of beta-PEA, much like amphetamine, depends on its ability to increase extracellular dopamine (DA) concentrations owing to reversal of the direction of dopamine transporter (DAT)-mediated DA transport. beta-PEA can also bind directly to the recently identified G protein-coupled receptors, but the physiological significance of this interaction is unclear. To assess the mechanism by which beta-PEA mediates its effects, we compared the neurochemical and behavioral effects of this amine in wild type (WT), heterozygous and 'null' DAT mutant mice. In microdialysis studies, beta-PEA, administered either systemically or locally via intrastriatal infusion, produced a pronounced outflow of striatal DA in WT mice whereas no increase was detected in mice lacking the DAT (DAT-KO mice). Similarly, in fast-scan voltammetry studies beta-PEA did not alter DA release and clearance rate in striatal slices from DAT-KO mice. In behavioral studies beta-PEA produced a robust but transient increase in locomotor activity in WT and heterozygous mice. In DAT-KO mice, whose locomotor activity and stereotypy are increased in a novel environment, beta-PEA (10-100 mg/kg) exerted a potent inhibitory action. At high doses, beta-PEA induced stereotypies in WT and heterozygous mice; some manifestations of stereotypy were also observed in the DAT-KO mice. These data demonstrate that the DAT is required for the striatal DA-releasing and hyperlocomotor actions of beta-PEA. The inhibitory action on hyperactivity and certain stereotypies induced by beta-PEA in DAT-KO mice indicate that targets other than the DAT are responsible for these effects.
Similar articles
- Voltammetric assessment of dopamine clearance in the absence of the dopamine transporter: no contribution of other transporters in core or shell of nucleus accumbens.
Mateo Y, Budygin EA, John CE, Banks ML, Jones SR. Mateo Y, et al. J Neurosci Methods. 2004 Dec 30;140(1-2):183-7. doi: 10.1016/j.jneumeth.2004.05.018. J Neurosci Methods. 2004. PMID: 15589348 - No role of the dopamine transporter in acute ethanol effects on striatal dopamine dynamics.
Mathews TA, John CE, Lapa GB, Budygin EA, Jones SR. Mathews TA, et al. Synapse. 2006 Sep 15;60(4):288-94. doi: 10.1002/syn.20301. Synapse. 2006. PMID: 16786536 - Phenotypic expression of the targeted null-mutation in the dopamine transporter gene varies as a function of the genetic background.
Morice E, Denis C, Giros B, Nosten-Bertrand M. Morice E, et al. Eur J Neurosci. 2004 Jul;20(1):120-6. doi: 10.1111/j.1460-9568.2004.03465.x. Eur J Neurosci. 2004. PMID: 15245485 - Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter.
Jones SR, Gainetdinov RR, Wightman RM, Caron MG. Jones SR, et al. J Neurosci. 1998 Mar 15;18(6):1979-86. doi: 10.1523/JNEUROSCI.18-06-01979.1998. J Neurosci. 1998. PMID: 9482784 Free PMC article. Review. - Rapid regulation of the dopamine transporter: role in stimulant addiction?
Zahniser NR, Sorkin A. Zahniser NR, et al. Neuropharmacology. 2004;47 Suppl 1:80-91. doi: 10.1016/j.neuropharm.2004.07.010. Neuropharmacology. 2004. PMID: 15464127 Review.
Cited by
- The Case for TAAR1 as a Modulator of Central Nervous System Function.
Rutigliano G, Accorroni A, Zucchi R. Rutigliano G, et al. Front Pharmacol. 2018 Jan 10;8:987. doi: 10.3389/fphar.2017.00987. eCollection 2017. Front Pharmacol. 2018. PMID: 29375386 Free PMC article. Review. - Behavioral outcomes of monoamine oxidase deficiency: preclinical and clinical evidence.
Bortolato M, Shih JC. Bortolato M, et al. Int Rev Neurobiol. 2011;100:13-42. doi: 10.1016/B978-0-12-386467-3.00002-9. Int Rev Neurobiol. 2011. PMID: 21971001 Free PMC article. Review. - Amphetamine activates/potentiates a ligand-gated ion channel.
Carvelli L. Carvelli L. Channels (Austin). 2014;8(4):294-5. doi: 10.4161/chan.29968. Channels (Austin). 2014. PMID: 25478621 Free PMC article. No abstract available. - Potential Functional Role of Phenethylamine Derivatives in Inhibiting Dopamine Reuptake: Structure-Activity Relationship.
Kundu D, Zhu A, Kim E, Paudel S, Jang CG, Lee YS, Kim KM. Kundu D, et al. Biomol Ther (Seoul). 2023 Jan 1;31(1):108-115. doi: 10.4062/biomolther.2022.047. Epub 2022 Sep 13. Biomol Ther (Seoul). 2023. PMID: 36098044 Free PMC article. - MDMA (Ecstasy) and human dopamine, norepinephrine, and serotonin transporters: implications for MDMA-induced neurotoxicity and treatment.
Verrico CD, Miller GM, Madras BK. Verrico CD, et al. Psychopharmacology (Berl). 2007 Jan;189(4):489-503. doi: 10.1007/s00213-005-0174-5. Epub 2005 Oct 12. Psychopharmacology (Berl). 2007. PMID: 16220332
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials